Use of androgens in patients with renal failure

Seminars in Dialysis

Volumn 13, Issue 1, 2000, Pages 36-39

  Johnson, Curtis A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; MALE; MORTALITY; PROGNOSIS; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

ANDROGENS; ANEMIA, IRON-DEFICIENCY; CLINICAL TRIALS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033631032     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139x.2000.00011.x     Document Type: Article

References (19)

1. Richardson JR, Weinstein MB: Erylhropoietic response of dialyzed patients to testosterone administration. Ann Intern Med 73:403-407, 1970
2. DeGowin RL, Lavender AR, Forland M, Charleston D, Gottschalk A: Erythropoiesis and erythropoietin in patients with chronic renal failure treated with hemodialysis and testosterone. Ann Intern Med 72:913-918, 1970
3. Teruel JL, Marcén R, Navarro JF, Villafruela JJ, Fernández Lucas M, Liaño F, Ortuño J: Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study. Nephron 70:282-286, 1995
4. Yared K, Gagnon RF, Brox AG: Mechanisms of action of androgen treatment on the anemia of experimental chronic renal failure [abstract]. J Am Soc Nephrol 8:633A, 1997
5. Hendler ED, Solomon L: Androgen therapy in hemodialysis patients: I. Effects on red cell oxygen transport. Kidney Int 31:100-106, 1987
6. Solomon LR, Hendler ED: Prospective controlled study of androgen therapy in the anemia of chronic renal disease: effects on iron kinetics. Acta Haematol 79:12-19, 1988
7. Neff MS, Goldberg J, Slifkin RF, Eiser AR, Calamia V, Kaplan M, Baez A, Gupta S, Mattoo N: A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med 304:871-875, 1981
8. Zevin D, Turani H, Cohen A, Levi J: Androgen-associated hepatoma in a hemodialysis patient. Nephron 29:274-276, 1981
9. Johnson FL, Feagler JR, Lerner KG, Majerus PW, Siegel M, Hartmann JR, Thomas ED: Association of androgenic-anabolic steroid therapy with development of hcpatocellular carcinoma. Lancet 2:1273-1276, 1972
10. Boyd PR, Mark GJ: Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years. Cancer 40:1765-1770, 1977
11. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined phase I and phase II clinical trial. N Engl J Med 316:73-78, 1987
12. Ballal SH, Domoto DT, Polack DC, Marciulonis P, Martin KJ: Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease. Am J Kidney Dis 17:29-33, 1991
13. Berns JS, Rudnick MR, Cohen RM: A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. Clin Nephrol 37:264-267, 1992
14. Gaughan WJ, Liss KA, Dunn SR, Mangold AM, Buhsmer JP, Michael B, Burke JF: A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Am J Kidney Dis 30:495-500, 1997
15. Teruel JL, Marcen R, Navarro-Antolin J, Aguilera A, Fernandez-Juarez G, Ortuño J: Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study. J Am Soc Nephrol 7:140-144, 1996
16. Teruel JL, Aguilera A, Marcen R, Antolin JN, Otero GG, Ortuño J: Androgen therapy for anaemia of chronic renal failure. Scand J Urol Nephrol 30:403-408, 1996
17. Navarro JF, Mora C, Rivero A, Macía M, Gallego E, Chahin J, Méndez M, García J: Androgens as therapy for the treatment of anemia in peritoneal dialysis (PD) patients [abstract]. Pent Dial Int 18(suppl I):S52, 1998
18. Gagnon RF, Yared K, Barré PA, Brox AG: Survey of the management of anemia in endstage renal disease (ESRD) [abstract]. J Am Soc Nephrol 8: 68A, 1997
19. Soliman G, Oreopoulos DG: Anabolic steroids and malnutrition in chronic renal failure. Perit Dial Int 14:362-365, 1994